Takeda is a patient-focused, innovation-driven global pharmaceutical company that builds on a distinguished 235-years history, aspiring to bring better health and a brighter future for people worldwide.
We know how debilitating illnesses like ulcerative colitis (UC) and Crohn’s disease (CD) can be. The pain, discomfort and unpredictability prevent patients from leading active lives, restrict their activities at work, and take a toll on families.
We also know how impactful the right treatment can be. Through patient-centered innovation, we develop medicines that go beyond treating disease and aim to find solutions that help turn a debilitating, restrictive illness into a manageable disease. www.takedaaustralia.com.au.
Stand/Booth No. 45